many of the hypolipidemics ( drugs that reduce levels of lipids in the blood ) have been available for more than 10 years , but only last year was one of these agents , cholestyramine ( questran ) , approved for use in the prevention of coronary heart disease .
C0018799
the
C0018787
heart